Tacrolimus reduces nitric oxide synthase function by binding to FKBP rather than by its calcineurin effect
Open Access
- 1 April 2009
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 75 (7), 719-726
- https://doi.org/10.1038/ki.2008.697
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Removal of Fkbp12/12.6 From Endothelial Ryanodine Receptors Leads to an Intracellular Calcium Leak and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- FK506 Binding Protein 12/12.6 Depletion Increases Endothelial Nitric Oxide Synthase Threonine 495 Phosphorylation and Blood PressureHypertension, 2007
- Impact of Tacrolimus and Mycophenolate Mofetil Combination on Cardiovascular Risk Profile after Kidney TransplantationJournal of the American Society of Nephrology, 2006
- Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in CaveolaePublished by Elsevier BV ,2004
- AT2‐Receptor activation regulates myocardial eNOS expression via the calcineurin‐NF‐AT pathwayThe FASEB Journal, 2002
- Cyclophilin-Mediated Pathways in the Effect of Cyclosporin A on Endothelial CellsCirculation Research, 2002
- Transcriptional Induction of Endothelial Nitric Oxide Gene by Cyclosporine APublished by Elsevier BV ,2000
- Effects of FK506 in rat and human resistance arteriesKidney International, 1999
- Mechanisms of FK 506–Induced Hypertension in the RatHypertension, 1999
- Single channel activity of the ryanodine receptor calcium release channel is modulated by FK‐506FEBS Letters, 1994